Ticker Details
Relay Therapeutics, Inc.
IPO Date:	July 16, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$2.68B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.61 | 3.36%
Avg Daily Range (30 D):	$0.42 | 4.02%
Avg Daily Range (90 D):	$0.30 | 3.26%

Institutional Daily Volume
Avg Daily Volume:	1.05M
Avg Daily Volume (30 D):	2.66M
Avg Daily Volume (90 D):	2.04M

Trade Size
Avg Trade Size (Sh.):	93
Avg Trade Size (Sh.) (30 D):	99
Avg Trade Size (Sh.) (90 D):	96

Institutional Trades
Total Institutional Trades:	2,646
Avg Institutional Trade:	$2.28M
Avg Institutional Trade (30 D):	$4.13M
Avg Institutional Trade (90 D):	$3M
Avg Institutional Trade Volume:	.16M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.83M
Avg Closing Trade (30 D):	$5.24M
Avg Closing Trade (90 D):	$3.42M
Avg Closing Volume:	207.99K

News

Mar 19, 2026 @ 7:03 PM Is Relay Therapeutics a Buy in 2026? One Instituti... Source: Andy Gould

Feb 23, 2026 @ 3:18 PM Spyre Therapeutics Stock Surges This Past Year as ... Source: Jonathan Ponciano

Feb 23, 2026 @ 3:01 PM Biotech Fund Dumps $84 Million of Nuvalent With St... Source: Jonathan Ponciano

Feb 19, 2026 @ 10:55 PM Relay Therapeutics to Announce Fourth Quarter and ... Source: Na

Feb 5, 2026 @ 2:35 PM $207B Market Shift: The Race for Fast Track Approv... Source: Prnewswire

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-1.61	$-.31	$-1.61
Diluted EPS	$-1.61	$-.31	$-1.61
Revenue	$15.36M	$7M	$15.36M
Gross Profit
Net Income / Loss	$-276.48M	$-54.89M	$-276.48M
Operating Income / Loss	$-302.74M	$-60.63M	$-302.74M
Cost of Revenue
Net Cash Flow	$-41.05M	$-8.47M	$-41.05M
PE Ratio